BIOMENDICS LLC has a total of 24 patent applications. It increased the IP activity by 1000.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are API GENESIS LLC, LIFELINE NUTRACEUTICALS CORP and UMBERT MILLET IGNACIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Hong Kong | 1 | |
#12 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry | |
#4 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tsai Chun-Che | 19 |
#2 | Mcguire Karen M | 19 |
#3 | Jamison James M | 11 |
#4 | Summers Jack L | 11 |
#5 | Mccormick Aleesha M | 8 |
#6 | Plocinik Emily L | 8 |
#7 | Mccormick Aleesha | 2 |
#8 | Jack L Summers | 2 |
#9 | Mcguire Karen | 2 |
#10 | Karen M Mcguire | 2 |
Publication | Filing date | Title |
---|---|---|
EP3658128A1 | Substituted tolans for the modulation of microbial colonization | |
KR20170141705A | Formulations and methods for controlling wound healing |